In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasing in vivo half-life using same

Details for Australian Patent Application No. 2010239861 (hide)

Owner Alteogen, Inc

Inventors Chung, Hye Shin; Yoo, Seung Bum; Lee, Sang Mee

Agent Pizzeys

Pub. Number AU-A-2010239861

PCT Pub. Number WO2010/123290

Priority 10-2009-0035190 22.04.09 KR

Filing date 22 April 2010

Wipo publication date 28 October 2010

International Classifications

C07K 14/475 (2006.01) Peptides having more than 20 amino acids

C07K 14/81 (2006.01) Peptides having more than 20 amino acids - Protease inhibitors

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

27 October 2011 PCT application entered the National Phase

  PCT publication WO2010/123290 Priority application(s): WO2010/123290

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010239873-Biodegradable implant and method for manufacturing same

2010239848-Storage bag and LPG fuel store